ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Islets"

  • 2019 American Transplant Congress

    Role of NF-kB in Release of Isletokines via Exosomes in Response to Islet Stress

    P. Saravanan1, M. Kanak1, J. Kalivarathan1, M. Lawrence2, M. Levy1, B. Naziruddin3

    1Department of Surgery, Virginia Commonwealth University, VCU Health, Richmond, VA, 2Islet Cell Lab, Baylor Scott and White Research Institute, Dallas, TX, 3Simmons Transplant Institute, Baylor Scott and White Medical Center, Dallas, TX

    *Purpose: Human islets are exposed to a range of inflammatory stimuli upon transplantation that leads to poor graft survival. Identifying the various signaling events may…
  • 2019 American Transplant Congress

    Blockade of IL-1β and TNF-α Does Not Significantly Pose Risk or Affect Outcomes in Patients Infused with Microbial-Positive Autologous Islet Preparations

    K. Kumano1, C. Darden2, S. Vasu1, M. Lawrence1, B. Naziruddin3, A. Gupta3, E. Beecherl3, N. Onaca3

    1Baylor Scott and White Research Institute, Dallas, TX, 2Baylor University, Waco, TX, 3Baylor Simmons Transplant Institute, Dallas, TX

    *Purpose: We recently demonstrated that the combined use of anakinra (IL-1β blocker) and etanercept (TNF-α blocker) improved outcomes of islet autotransplantation after total pancreatectomy (TPIAT).…
  • 2019 American Transplant Congress

    B Cell IL-4 Signaling Induces the IL-10 Secreting TIM-1+ Bregs and Suppresses T Cell Inflammatory Cytokines

    Z. Song, K. Mohib, D. M. Rothstein

    Surgery, Starzl Transplantation Institute, Pittsburgh, PA

    *Purpose: TIM-1+ identifies the majority (~75%) of IL-10+ B regulatory cells (Bregs). However, TIM-1+ B cells are also enriched for IL-4+ B effector 2 cells…
  • 2019 American Transplant Congress

    Fibrosis Scoring Correlates with Progression of Chronic Pancreatitis, Islet Isolation Yields and Transplant Outcomes in Patients Undergoing Islet Autotransplantation

    Y. Liu1, J. SoRelle2, K. Kumano3, S. Vasu3, M. Lawrence4, A. Gupta1, N. Onaca1, E. Beecherl1, B. Naziruddin4

    1Baylor Simmons Transplant Institute, Dallas, TX, 2UTSouthwestern Medical Center, Dallas, TX, 3Baylor Scott and White Research Institute, Dallas, TX, 4Baylor University Medical Ctr, Dallas, TX

    *Purpose: Total pancreatectomy with autologous islet transplantation (TPIAT) is a promising procedure for alleviating pain and maintaining glucose homeostasis in chronic pancreatitis (CP) patients. However,…
  • 2019 American Transplant Congress

    Long Term Renal Function Following Islet Transplantation in the Clinical Islet Transplantation Consortium

    L. G. Hunsicker1, T. L. Eggerman2, M. R. Rickels3, t. Clinical Islet Transplantation (CIT) Consortium4

    1Internal Medicine, U. Iowa, Iowa City, IA, 2NIDDK/NIH, Bethesda, MD, 3Internal Medicine, U. Pennsylvania, Philadelphia, PA, 4Internal Medicine, University of Iowa, Iowa City, IA

    *Purpose: Islet transplantation (IsletTp) is safe and effective treatment of Type 1 diabetes complicated by severe hypoglycemia (Diabetes Care 2016, 39:1230). But the requirement for…
  • 2019 American Transplant Congress

    Outcomes of Total Pancreatectomyand Islet Autotransplantation, a Single Center Experience

    A. Rajab1, J. Buss1, L. F. Lara2, S. Meng3, K. Kuntz4, D. Conwell2, P. A. Hart2, K. Washburn1

    1Transplant Surgery, The Ohio State University, Columbus, OH, 2Gastroenterology, Hepatology and Nutrition, The Ohio State University, Columbus, OH, 3Endocrinology, Diabetes and Metabolism, The Ohio State University, Columbus, OH, 4Psychiatry and Behavioral Health, The Ohio State University, Columbus, OH

    *Purpose: Patients with chronic pancreatitis (CP) suffer from severe pain that greatly reduces their quality of life and often leads to long-term narcotic therapy to…
  • 2019 American Transplant Congress

    Withaferin A Shifts Circulating Lymphocytes toward Protective T Cell Subsets and Prolongs Islet Allograft Survival in a Mouse Transplant Model

    K. Kumano1, M. Kanak2, C. Darden3, S. Vasu1, Y. Liu4, M. C. Lawrence1, B. Naziruddin4

    1Baylor Scott and White Research Institute, Dallas, TX, 2Department of Surgery, Virginia Commonwealth University, Richmond, VA, 3Institute of Biomedical Studies, Baylor University, Waco, TX, 4Baylor Simmons Transplant Institute, Dallas, TX

    *Purpose: : Immunosuppression protocols improve the efficacy of allogeneic islet transplantation. However, decline in islet graft function and toxicities imposed by current immunosuppressant drugs remain…
  • 2019 American Transplant Congress

    Can Cxcl8 Inhibitor (reparixin) Improve Islet Engraftment And Clinical Outcomes After Islet Allotransplantation? University Of Chicago Preliminary Results From A Phase 3 Multicenter Randomized, Double-blinded, Prospective Study.

    P. Bachul1, K. Golab1, L. Basto1, L. Wang1, M. Tibudan1, J. Golebiewska2, M. Para1, L. Perea1, F. Antic1, J. Fung1, P. Witkowski1

    1University of Chicago Medicine, Chicago, IL, 2Medical University of Gdansk, Gdansk, Poland

    *Purpose: Reparixin is a novel CxCR1/2 chemokine receptor-blocking molecule, which has been shown improving islet engraftment in animal models. A multicenter trial was organized to…
  • 2019 American Transplant Congress

    Analysis of Islet Exosomal miRNAs Released Post-Transplant in Response to Inflammation

    P. Saravanan1, M. Kanak1, G. Yoshimatsu2, C. Darden2, M. Lawrence2, M. Levy1, B. Naziruddin3

    1Department of Surgery, Virginia Commonwealth University, VCU Health, Richmond, VA, 2Islet Cell Lab, Baylor Scott and White Research Institute, Dallas, TX, 3Simmons Transplant Institute, Baylor Scott and White Research Center, Dallas, TX

    *Purpose: Islets release miRNAs and other non-coding RNAs via exosomes under various pathological conditions, which are capable of regulating the genes of neighboring and/or distant…
  • 2019 American Transplant Congress

    Clinical Trial of Allogeneic Islet Transplantation in the Treatment of Diabetes after Renal Transplantation

    W. liang, M. Hu, G. Peng, D. Zhou, C. Zeng, W. Zhou, q. Ye, Z. Wang

    Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases, Wuhan, China

    *Purpose: Diabetes after renal transplantation is one of the most serious complications after renal transplantation. It has a serious impact to the survival of kidney…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 22
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences